NCT06102369 The Role of Narrow Band Imaging (NBI) Bronchoscopy in Detecting Bronchial Squamous Dysplasia in Lung Cancer Status ENROLLING_BY_INVITATION Phase N/A
NCT06102161 Wedge Resection for Ground-glass Opacity-featured Lung Cancer (ECTOP-1020) Status NOT_YET_RECRUITING Phase PHASE3
NCT06101394 Development of a Fluorescent Visualization System for Non-visible Lung Cancer Nodules Status RECRUITING Phase PHASE2
NCT06091930 A Study to Test Different Doses of BI 765049 Alone and in Combination With Ezabenlimab in Asian People With Advanced Cancer (Solid Tumours) Positive for B7-H6 Status TERMINATED Phase PHASE1
NCT06086587 Development and Application of Molecular Evaluation Instrument for Lung Cancer Diagnosis and Treatment Status NOT_YET_RECRUITING Phase N/A
NCT06084208 Assessment of Diagnostic Yield Using a Robotic Navigational Bronchoscopy System With CBCT Status COMPLETED Phase NA
NCT06081270 Prospective Study on Resistance-associated Mutations in Metastatic Lung Cancer Status RECRUITING Phase N/A
NCT06080061 Personalized Accelerated ChEmoRadiation (PACER) for Lung Cancer Status RECRUITING Phase PHASE1
NCT06065592 Exploring Cancer-Associated Thromboembolism Prognosis Biomarkers and Polymorphisms Status RECRUITING Phase PHASE1
NCT06060613 Safety and Efficacy of OBX-115 in Advanced Solid Tumors Status RECRUITING Phase PHASE1/PHASE2
NCT06056128 Confirmation of Accuracy of the Tool-in-lesion Technology (TiLT) of the Galaxy System With Integrated TOMO Technology Status ACTIVE_NOT_RECRUITING Phase NA
NCT06055465 Neoadjuvant Sacituzumab Govitecan Plus Pembrolizumab in Resectable Non-Small Cell Lung Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT06054854 Biobank for the Identification of Biomarkers in Lung Cancer (BIRD, Biomarkers in Respiratory Disease) Status RECRUITING Phase N/A
NCT06052449 Assessing Social Determinants of Health to Increase Cancer Screening Status COMPLETED Phase NA
NCT06051695 A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression Status RECRUITING Phase PHASE1/PHASE2
NCT06051136 Early Versus Delayed Rehabilitation Intervention in Patients With Lung Cancer Status ACTIVE_NOT_RECRUITING Phase NA
NCT06048367 Carbon Nanoparticle-Loaded Iron [CNSI-Fe(II)] in the Treatment of Advanced Solid Tumor Status COMPLETED Phase PHASE1